These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 4008922)

  • 1. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.
    Anderson RM; May RM
    J Hyg (Lond); 1985 Jun; 94(3):365-436. PubMed ID: 4008922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM; Grenfell BT
    J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling forces of infection for measles, mumps and rubella.
    Farrington CP
    Stat Med; 1990 Aug; 9(8):953-67. PubMed ID: 2218197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against rubella and measles: quantitative investigations of different policies.
    Anderson RM; May RM
    J Hyg (Lond); 1983 Apr; 90(2):259-325. PubMed ID: 6833747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years of serological surveillance in England and Wales: methods, results, implications and action.
    Osborne K; Gay N; Hesketh L; Morgan-Capner P; Miller E
    Int J Epidemiol; 2000 Apr; 29(2):362-8. PubMed ID: 10817137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles in developing countries. Part I. Epidemiological parameters and patterns.
    McLean AR; Anderson RM
    Epidemiol Infect; 1988 Feb; 100(1):111-33. PubMed ID: 3338500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.
    Babad HR; Nokes DJ; Gay NJ; Miller E; Morgan-Capner P; Anderson RM
    Epidemiol Infect; 1995 Apr; 114(2):319-44. PubMed ID: 7705494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination.
    Grenfell BT; Anderson RM
    Proc R Soc Lond B Biol Sci; 1989 Apr; 236(1284):213-52. PubMed ID: 2567004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
    Buxbaum S; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.
    Gay NJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Infect; 1995 Aug; 115(1):139-56. PubMed ID: 7641827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G; Gareca M; Kincaid H; Knouse MC
    J Travel Med; 2015; 22(6):396-402. PubMed ID: 26412393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas].
    Oliveira J; Dias N; Ferreira TM; da Cunha S; Costa D; Côrte-Real R; Meliço-Silvestre A
    Acta Med Port; 1999; 12(4-6):155-60. PubMed ID: 10481316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014.
    Zurynski YA; McRae JE; Quinn HE; Wood NJ; Macartney KK
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E391-E400. PubMed ID: 28278415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measles in the Jassy district: 1951-1979].
    Oană C; Teodorovici G; Dimitriu G; Baciu F; Alexandru D; Timpău M; Iacob M; Groll M; Dimofte S
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(3):406, 420, 436. PubMed ID: 7244458
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
    Vyse AJ; Gay NJ; White JM; Ramsay ME; Brown DW; Cohen BJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Rev; 2002; 24(2):125-36. PubMed ID: 12762088
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry.
    Ramondetti F; Sacco S; Comelli M; Bruno G; Falorni A; Iannilli A; d'Annunzio G; Iafusco D; Songini M; Toni S; Cherubini V; Carle F;
    Diabet Med; 2012 Jun; 29(6):761-6. PubMed ID: 22133003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML; Martínez D; Santos-Sancho JM; Borda JR; Orero A
    Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles, mumps, rubella, and varicella among service members and other beneficiaries of the Military Health System, 2010-2016.
    Williams VF; Stahlman S; Fan M
    MSMR; 2017 Oct; 24(10):2-11. PubMed ID: 29077422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.